Toth Financial Advisory Corp Takes $635,000 Position in Establishment Labs Holdings Inc. $ESTA

Toth Financial Advisory Corp bought a new stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 7,400 shares of the company’s stock, valued at approximately $635,000.

Several other hedge funds also recently bought and sold shares of ESTA. KBC Group NV bought a new stake in Establishment Labs during the first quarter valued at about $28,000. Quarry LP bought a new position in shares of Establishment Labs in the third quarter worth about $34,000. Northwestern Mutual Wealth Management Co. bought a new position in shares of Establishment Labs in the second quarter worth about $43,000. Kestra Advisory Services LLC bought a new position in shares of Establishment Labs in the fourth quarter worth about $47,000. Finally, Osaic Holdings Inc. grew its position in shares of Establishment Labs by 900.0% during the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after purchasing an additional 1,800 shares in the last quarter. Institutional investors own 72.91% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Citigroup raised Establishment Labs from a “neutral” rating to a “buy” rating and set a $92.00 target price on the stock in a research note on Thursday, August 13th. Mizuho upped their price target on Establishment Labs from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 15th. Needham & Company LLC increased their price objective on shares of Establishment Labs from $86.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, August 6th. TD Cowen lifted their price objective on shares of Establishment Labs from $95.00 to $117.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Finally, BTIG Research boosted their target price on shares of Establishment Labs from $96.00 to $103.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $100.25.

Establishment Labs Trading Down 1.6%

Shares of ESTA stock opened at $70.64 on Friday. The company has a market cap of $2.11 billion, a PE ratio of -53.92 and a beta of 1.07. Establishment Labs Holdings Inc. has a 1 year low of $36.53 and a 1 year high of $97.59. The stock’s 50 day simple moving average is $85.00 and its two-hundred day simple moving average is $74.91. The company has a debt-to-equity ratio of 12.11, a current ratio of 3.84 and a quick ratio of 2.52.

Establishment Labs (NASDAQ:ESTA) last released its earnings results on Thursday, August 6th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.05). Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%.The firm had revenue of $67.54 million during the quarter, compared to the consensus estimate of $65.79 million. During the same quarter last year, the business posted ($0.57) EPS. Establishment Labs’s revenue was up 31.7% compared to the same quarter last year. Research analysts predict that Establishment Labs Holdings Inc. will post -1.15 earnings per share for the current year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.